Name:	rckt_AgreementTerminationNoticePeriod
Namespace Prefix:	rckt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

License Agreement Abstract

No definition available.

Name:	rckt_LicenseAgreementAbstract
Namespace Prefix:	rckt_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

The number of patents under the agreement.

No definition available.

Name:	rckt_LicenseAgreementNumberOfPatents
Namespace Prefix:	rckt_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Term of options right to expiry from the date of the license agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

No definition available.

Name:	rckt_LicenseAgreementOptionsRightExpiryTerm
Namespace Prefix:	rckt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Refers to the number of least uninterrupted years following regulatory approval to develop or commercialize at least one product or process covered by the licensed intellectual property in at least one country.

No definition available.

Name:	rckt_NumberOfLeastUninterruptedYears
Namespace Prefix:	rckt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Number of milestones achieved during the period.

No definition available.

Name:	rckt_NumberOfMilestonesAchieved
Namespace Prefix:	rckt_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Payment and expenses for license fee.

No definition available.

Name:	rckt_PaymentAndExpensesForLicenseFee
Namespace Prefix:	rckt_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

The term of the agreement from the commencement date, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

No definition available.

Name:	rckt_ResearchAgreementInitialTerm
Namespace Prefix:	rckt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

The research and development costs incurred during the period.

No definition available.

Name:	rckt_ResearchAndDevelopmentCosts
Namespace Prefix:	rckt_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Aggregate milestone potential future obligations as of the balance sheet date.

No definition available.

Name:	rckt_ResearchAndDevelopmentCostsPotentialFutureObligation
Namespace Prefix:	rckt_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Royalties percentage payable on fees received from a priority review voucher issued in connection with or otherwise related to a licensed product.

No definition available.

Name:	rckt_RoyaltiesPayableOnFeesReceived
Namespace Prefix:	rckt_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

Name:	us-gaap_TypeOfArrangementAxis=rckt_DanonDiseaseLicenseAgreementWithUCSDMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=rckt_REGENXBIOIncLicenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=rckt_LicenseAgreementsWithCIEMATMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=rckt_LicenseAgreementForLADIWithCIEMATAndUCLBMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: